Click here to go to the previous page
Globalization of Phase 1: Trends and Challenges
Program Code:
274
Date:
Tuesday, June 26, 2012
Time:
3:30 PM to 4:30 PM
EST
CHAIR
:
He has an extensive background in neonatal and pediatric pharmacology and is the co-author and co-publisher of the leading drug dosing manual, NeoFax. He has represented the interest of pediatric patients by chairing and speaking at on the topic of neonatal pharmacology and legislative issues.
|
PRESENTER
(S):
Min Soo Park, Yonsei University; KoNECT, Republic of Korea
Savita Dhillon, M.D. is Medical Director, Medanta Duke Research Institute (MDRI) joint venture clinical research collaboration between Duke Medicine and Medanta –The Medicity in Gurgaon, India.
|
Description
This showcase will discuss trends, challenges and perspectives with speakers/panelists who are directly involved in the globalization of early phase research. Developed by Clinical Pharmacology (CP) SIAC.
Learning Objectives:
Discuss the motivations for globalization early-phase clinical research
Identify logistic, regulatory, business cultural, and political challenges of "off-shore" phase 1
Recognize current status and trends of phase 1 globalization.